Cargando…
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study
Bisphosphonates (BPs) are used intravenously to treat cancer-related conditions for the prevention of pathological fractures. Osteonecrosis of the jaw (BRONJ) is a rare complication reported in 4–15% of patients. We studied, retrospectively, 55 patients with multiple myeloma or Waldenstrom's ma...
Autores principales: | Andriani, A, Petrucci, M T, Caravita, T, Montanaro, M, Villivà, N, Levi, A, Siniscalchi, A, Bongarzoni, V, Pisani, F, De Muro, M, Coppetelli, U, Avvisati, G, Zullo, A, Agrillo, A, Gaglioti, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317527/ https://www.ncbi.nlm.nih.gov/pubmed/22829257 http://dx.doi.org/10.1038/bcj.2012.9 |
Ejemplares similares
-
Cutaneous macroglobulinosis with Waldenström macroglobulinemia
por: Hassab-El-Naby, Hussein M.M., et al.
Publicado: (2020) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)
por: Bedogni, A, et al.
Publicado: (2012) -
Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2016) -
Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2015)